ACTRI at UCSD Health

Contact Us:

9452 Medical Center Drive
La Jolla, CA 92037
Phone: (858) 246-5417
Fax: (858) 246-2255

Current Clinical Trials:

​Clinical trials of innovative therapies designed to halt the progression of and reverse liver injury are currently underway at UC San Diego Health. Through research, important advances in the treatment of liver disease continues to emerge. Currently we have several drug trials and observational studies mainly related to Nonalcoholic Fatty Liver Disease (NAFLD) and pharmaceutical trials for patients with NAFLD, nonalcoholic steatohepatitis (NASH), and NASH cirrhosis. For information, call 858-246-2179.

Liver Center: Research and Clinical Trials
Learn More about NAFLD Treatment

Liver Calc includes clinical tools and content intended for use by healthcare professionals. These tools do not give professional advice; physicians and other healthcare professionals who use these tools or databases should exercise their own clinical judgment as to the information they provide. Consumers (non-medical professionals) who use the tools or databases do so at their own risk. Individuals with any type of medical condition are specifically cautioned to seek professional medical advice before beginning any sort of health treatment. For medical concerns, including decisions about medications and other treatments, non-medical users users should always consult their physician or other qualified healthcare professional.

Liver Calc's content developers have carefully tried to create its content to conform to the standards of professional practice that prevailed at the time of development. However, standards and practices in medicine change as new data become available and the individual medical professional should consult a variety of sources. The contents of the Liver Calc site and apps, such as text, graphics, and images are for informational purposes only. Liver Calc does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned on the site.

UC San Diego NAFLD Research Center
Altman Clinical and Translational Research Institute
9452 Medical Center Drive La Jolla, CA 92037


Beom Kyung Kim1,2, Jaclyn Bergstrom1, Rohan Loomba1, Nobuharu Tamaki1,5, Namiki Izumi5, Atsushi Nakajima1,6, Ramazan Idilman7, Mesut Gumussoy7, Digdem Kuru Oz8, Ayse Erden8, Emily Truong9, Ju Dong Yang9, Mazen Noureddin9, Alina M. Allen10 and Rohit Loomba1,11, Veeral Ajmera1

1NAFLD Research Center, Division of Gastroenterology. University of California at San Diego, La Jolla, CA, USA 2Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea 3Division of Internal Medicine, Conemaugh Memorial Medical Center, Johnstown, PA, USA 4Evidence-Based Practice Center, Mayo Clinic, Rochester, MN, USA 5Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital Tokyo, Japan 6Department of Gastroenterology and Hepatology, Yokohama City University, Yokohama, Japan 7Ankara University School of Medicine, Department of Gastroenterology, Ankara Turkey 8Ankara University School of Medicine, Department of Radiology, Ankara Turkey. 9Department of Gastroenterology and Hepatology, Cedars Sinai, Los Angeles, CA, USA 10Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA 11School of Public Health, University of California, San Diego

Copyright © 2023 Justin Yeung